Industry News - BioPharm International

ADVERTISEMENT

Industry News
The latest news about industry suppliers, business activities, people.

DepoVax Technology Selected for HPV–related Cancer Trials

April 17, 2014

Immunovaccine's vaccine technology chosen for cervical, head, and neck cancer trials conducted by Dana-Farber Institute.

Novartis's Bexsero Receives FDA Breakthrough Therapy Designation

April 17, 2014

Novartis receives FDA breakthrough therapy designation for Bexsero, a meningitis B vaccine.

PolyTherics and MacroGenics Extend ADC Collaboration

April 11, 2014

ThioBridge linker technology to attach different payloads to a range of antibodies

Desktop Human Body Developed for Toxicity Testing

April 10, 2014

The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.

uniQure Announces Management Changes

April 10, 2014

uniQure appoints a new COO and vice president, Medical affairs.

Immunovaccine Presents New Cancer Vaccine Data at AACR

April 7, 2014

Immunovaccine reports enhanced cancer vaccine combination therapies at 2014 AACR Annual Meeting.

Recurrent Head and Neck Tumors Could be Vulnerable to Cancer Drug

April 7, 2014

New research finds that recurrent head and neck tumors have gene mutations that could be vulnerable to the cancer drug dasatinib.

Novartis and Malaria No More Campaign Provide Antimalarial Treatments in Zambia

April 7, 2014

Novartis delivers 2 million treatments of its pediatric antimalarial to Zambia in collaboration with Malaria No More's Power of One campaign.

A New Plant Biotech Approach for Efficient Production of Pharmaceutical Compound

April 7, 2014

European scientists have discovered a method to improve the efficiency of the pharmaceutical production through plant biotechnology.

ADVERTISEMENT

ADVERTISEMENT

Click here